Michigan eArly disease Progression cohort in COPD (MAP-COPD)

Overview

The Michigan eArly disease Progression cohort in COPD (MAP-COPD) study is a research initiative focused on understanding the progression of chronic obstructive pulmonary disease (COPD).  The study aims to enhance knowledge regarding screening for COPD and to assess the burden of early-stage COPD in patients.  By identifying factors that contribute to disease onset and early progression, MAP-COPD seeks to uncover biomarkers and mechanisms that could inform early diagnosis and intervention strategies, with the goal of developing personalized treatment approaches that can slow disease progression and improve patient outcomes.

Principal Investigator

Meilan Han, MD, MS

Digital Health Innovation Support

Digital Health Innovation provided genetic data for this project.